Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial REPLY
- 1 May 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 203 (5) , 977
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive BladderJournal of Urology, 2017
- Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year StudyJournal of Urology, 2016
- Discontinuation rates and inter‐injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivityInternational Journal of Urology, 2013
- Repeated Botulinum Toxin Type A Injections for Refractory Overactive Bladder: Medium-Term Outcomes, Safety Profile, and Discontinuation RatesEuropean Urology, 2012